Cargando…
Synergistic actions of FGF2 and bone marrow transplantation mitigate radiation-induced intestinal injury
Unwanted radiological or nuclear exposure remains a public health risk for which effective therapeutic countermeasures are lacking. Here, we evaluated the efficacy of fibroblast growth factor-2 (FGF2) in treating radiation-induced gastrointestinal syndrome (RIGS) incurred by lethal whole-body irradi...
Autores principales: | Kim, Byoung Hyuck, Jung, Hee-Won, Seo, Seok Hyun, Shin, Hyemi, Kwon, Jeanny, Suh, Jae Myoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841425/ https://www.ncbi.nlm.nih.gov/pubmed/29515101 http://dx.doi.org/10.1038/s41419-018-0421-4 |
Ejemplares similares
-
Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database
por: Kim, Byoung Hyuck, et al.
Publicado: (2018) -
Bone Marrow Stromal Cell Transplantation Mitigates Radiation-Induced Gastrointestinal Syndrome in Mice
por: Saha, Subhrajit, et al.
Publicado: (2011) -
Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage
por: Liu, Wei, et al.
Publicado: (2015) -
Actions to Mitigate the Radiation Damage to Electronics at the LHC
por: Perrot, A L, et al.
Publicado: (2013) -
Rescuing Self: Transient Isolation and Autologous Transplantation of Bone Marrow Mitigates Radiation-Induced Hematopoietic Syndrome and Mortality in Mice
por: Ghosh, Subhajit, et al.
Publicado: (2017)